Table 3 |
||||
|
Mean clinical biochemistry values of female rats administered PGX® for 90 days |
||||
|
Parameter (units) |
Control |
1.25% |
2.5% |
5.0% |
|
|
||||
|
Aspartate Aminotransferase (U/L) |
84 ± 13 |
86 ± 6 |
88 ± 10 |
101 ± 18a |
|
Alanine Aminotransferase (U/L) |
32 ± 3 |
38 ± 4 |
40 ± 7 |
54 ± 14a |
|
Sorbitol Dehydrogenase (U/L) |
10.0 ± 2.0 |
9.2 ± 1.7 |
10.3 ± 2.2 |
10.4 ± 2.0 |
|
Alkaline Phosphatase (U/L) |
87 ± 31 |
97 ± 18 |
89 ± 25 |
103 ± 24 |
|
Total Bilirubin (mg/dL) |
0.16 ± 0.03 |
0.16 ± 0.02 |
0.16 ± 0.02 |
0.18 ± 0.02 |
|
Blood Urea Nitrogen (mg/dL) |
18 ± 2 |
17 ± 2 |
19 ± 1 |
18 ± 2 |
|
Creatinine (mg/dL) |
0.41 ± 0.03 |
0.42 ± 0.04 |
0.44 ± 0.03 |
0.43 ± 0.04 |
|
Cholesterol (mg/dL) |
98 ± 8 |
106 ± 11 |
102 ± 16 |
111 ± 13 |
|
Triglycerides (mg/dL) |
25 ± 5 |
31 ± 8 |
29 ± 8 |
34 ± 8a |
|
Glucose (mg/dL) |
115 ± 8 |
111 ± 7 |
115 ± 10 |
111 ± 7 |
|
Total Protein (g/dL) |
6.5 ± 0.3 |
6.5 ± 0.2 |
6.5 ± 0.3 |
6.4 ± 0.3 |
|
Albumin (g/dL) |
3.5 ± 0.2 |
3.5 ± 0.2 |
3.5 ± 0.2 |
3.5 ± 0.2 |
|
Globulin (g/dL) |
3.0 ± 0.2 |
3.0 ± 0.2 |
3.1 ± 0.2 |
2.9 ± 0.2 |
|
Calcium (mg/dL) |
10.7 ± 0.4 |
10.6 ± 0.3 |
10.5 ± 0.1 |
10.7 ± 0.4 |
|
Inorganic Phosphorus (mg/dL) |
5.9 ± 0.5 |
5.5 ± 0.6 |
4.9 ± 0.4b |
5.4 ± 0.7 |
|
Sodium (mmol/L) |
143.5 ± 5.8 |
141.0 ± 6.9 |
143.4 ± 5.6 |
136.6 ± 5.1b |
|
Potassium (mmol/L) |
5.02. ± 0.28 |
4.88 ± 0.25 |
4.89 ± 0.25 |
4.71 ± 0.25b |
|
Chloride (mmol/L) |
104.9 ± 4.0 |
102.3 ± 5.1 |
104.8 ± 3.4 |
100.4 ± 3.b |
|
|
||||
|
a Statistically different from control (P ≤ 0.05) by Dunn's test; b Statistically different from control (P≤ 0.05) by Dunnett test |
||||
|
Matulka et al. Nutrition Journal 2009 8:1 doi:10.1186/1475-2891-8-1 |
||||